Updated Jul 16, 2026
McLaughlin Gerald W. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Gerald W. McLaughlin is a corporate executive currently serving as a Director at Allarity Therapeutics, Inc. His professional background includes experience in the biotechnology and pharmaceutical sectors, although specific details about his career history are not widely documented.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-07 | ALLR | Allarity Therapeutics, Inc. | A — Grant or award | 45.0K | $0.00 |
Gerald W. McLaughlin is a corporate executive currently serving as a Director at Allarity Therapeutics, Inc. His professional background includes experience in the biotechnology and pharmaceutical sectors, although specific details about his career history are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McLaughlin Gerald W. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.